Earnings are out
NEUP · NASDAQ · Biotechnology

Neuphoria Therapeutics (NEUP)

Develops BNC210 for anxiety and trauma-related disorders through virtualized clinical development.

$3.75
At close−0.04 (−1.06%)

Breakdown13F · 13D/G · Form 4

Institutions19 holders · as of Mar 31, 202632.53%1.76M shares
Otherremainder67.47%3.65M shares

5.40M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Lynx1 Capital Management LPInstitution
16.20%875,32813Fas of Mar 31, 2026
Advisorshares Investments LLCInstitution
2.87%155,36713Fas of Mar 31, 2026
Shay Capital LLCInstitution
2.79%151,01013Fas of Mar 31, 2026
Balyasny Asset Management L.P.Institution
2.63%142,18313Fas of Mar 31, 2026
Vanguard Capital Management LLCInstitution
1.82%98,51613Fas of Mar 31, 2026
Squadron Capital Management LLCInstitution
1.42%76,72813Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.96%52,00713Fas of Mar 31, 2026
Ikarian Capital, LLCInstitution
0.88%47,44313Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.62%33,58913Fas of Mar 31, 2026
Adar1 Capital Management, LLCInstitution
0.56%30,00013Fas of Mar 31, 2026
FNY Investment Advisers, LLCInstitution
0.49%26,50013Fas of Mar 31, 2026
Citadel Advisors LLCInstitution
0.36%19,33113Fas of Mar 31, 2026
Boothbay Fund Management, LLCInstitution
0.26%14,00013Fas of Mar 31, 2026
Virtu Financial LLCInstitution
0.22%12,03313Fas of Mar 31, 2026
Commonwealth Equity Services, LLCInstitution
0.21%11,22213Fas of Mar 31, 2026
Merck & Co., Inc.Institution
0.19%10,02713Fas of Mar 31, 2026
UBS Group AGInstitution
0.04%2,31613Fas of Mar 31, 2026
Rhumbline AdvisersInstitution
0.00%20213Fas of Mar 31, 2026
Morgan StanleyInstitution
0.00%5813Fas of Mar 31, 2026
Apeiron Investment Group Ltd.Strategic
27.70% of class, as filed13Dfiled Dec 30, 2021
Armistice Capital, LLCStrategic
9.99% of class, as filed13D/Gfiled Nov 14, 2024
Coastlands Capital LPInstitution
5.10% of class, as filed13Gfiled Nov 5, 2025
Point72 Asset Management, L.P.Institution
8.10% of class, as filed13Gfiled Sep 29, 2023

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more

Institutions13F, as of Mar 31, 2026

19 holders · 1.76M shares · 6 new positions · 11 increased · 1 reduced · 8 closed

HolderShares% outstandingChg q/qFiled
LYNX1 Capital Management LP875.3K16.20%+100May 4, 2026
Advisorshares Investments LLC155.4K2.87%+21.2KApr 28, 2026
Shay Capital LLC151.0K2.79%−18.0KMay 15, 2026
Balyasny Asset Management L.P.142.2K2.63%+142.2KnewMay 15, 2026
Vanguard Capital Management LLC98.5K1.82%+98.5KnewMay 15, 2026
Squadron Capital Management LLC76.7K1.42%+76.7KnewMay 15, 2026
Geode Capital Management, LLC52.0K0.96%+34.7KMay 15, 2026
Ikarian Capital, LLC47.4K0.88%0May 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Lynx1 Capital Management LPincl. Weston Nichols16.30%875.3K13DDec 29, 2025
Armistice Capital, LLCincl. Steven Boyd9.99%Nov 14, 2024
Shay Capital LLC7.30%171.6K13GOct 31, 2025
Coastlands Capital LP5.10%120.0K13GNov 5, 2025

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Oct 21, 2025
Lynx1 Capital Management LP10 percent owner
Purchase639,110$5.14875,328

CongressHouse and Senate disclosures

Not reported.